Semaglutide Approved in Canada: It’s Time to Change the Game

2022-04-08T13:58:10-04:00November 29th, 2021|Categories: OC News|Tags: , , , , , , |

by Ian Patton, PhD, Director of Advocacy and Public Engagement, Obesity Canada After a long anticipated wait, the day has come where Health Canada has approved a new treatment option for the management of obesity in the form of the medication [...]

Response to the CADTH draft recommendations on coverage of Saxenda

2021-07-02T14:30:29-04:00June 29th, 2021|Categories: OC News|Tags: , , |

On June 10th, 2021 the Canadian Agency for Drugs and Technology in Health (CADTH), an independant, not-for-profit organization responsible for providing Canadian decision makers with objective evidence about the optimal usage of drugs and medical devices, released a draft of their [...]

Go to Top